Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load
Clinical trial NCT04336943 · TERMINATED
Trial details
- NCT number
- NCT04336943
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-13
- Primary completion
- 2024-06-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.